Furthermore, the mutation order of JAK2 V617F and DNMT3A is associated with differences in MPN phenotype, underlying the importance of the pattern of acquisition of JAK2 V617F with respect to mutations in epigenetic modifiers in influencing the phenotype of MPN [52]. The gene discussed is JAK2; the disease is myeloproliferative neoplasm.